astragaloside a has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Huang, S; Le, B; Li, S; Li, W; Mo, Y; Pan, H; Wang, Q; Wang, S; Wei, R; Wen, H; Xu, E; Yang, C; Zheng, J | 1 |
1 other study(ies) available for astragaloside a and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson's disease mouse model.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Dopaminergic Neurons; Inflammasomes; Lipopolysaccharides; Male; Mice, Inbred C57BL; Microglia; Motor Activity; MPTP Poisoning; Neuroprotective Agents; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Rats; Saponins; Triterpenes | 2019 |